RxDoctor Payments Data

Leland Heller, MD

Family Medicine · Okeechobee, FLNPI 1184785438

Payments from drug & device makers

$7,156in general payments, 2019–2025

Across 209 payments — averaging $34.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • Novo Nordisk$303
  • Lilly USA, LLC$214
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$200
  • Johnson & Johnson$151
  • Pfizer$144
  • plus $1K from 25 others

What the payments were for

  • Speaking & faculty fees$3,77553%
  • Travel & lodging$1071%
  • Food & beverage$3,17144%
  • Education$1031%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,156 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$2,676
Medicare patients
58
Services billed
64

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$24,868
OzempicSemaglutide21$19,532
XareltoRivaroxaban13$16,775
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$10,728
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,552
Albuterol Sulfate HfaAlbuterol Sulfate41$1,448
Atorvastatin Calcium147$1,277
Fluoxetine Hcl108$797
Metoprolol Succinate80$790
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine22$757
Carbamazepine25$632
Gabapentin43$628
Rosuvastatin Calcium36$512
Chlorthalidone47$490
Potassium Chloride33$463

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$144$24,86817 claims
Novo NordiskOzempic$303$19,53221 claims
Johnson & JohnsonXarelto$151$16,77513 claims
Lilly USA, LLCOlanzapine$214$34828 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Okeechobee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →